Leonard R Duncan

1.3k total citations
53 papers, 1.0k citations indexed

About

Leonard R Duncan is a scholar working on Molecular Medicine, Pharmacology and Infectious Diseases. According to data from OpenAlex, Leonard R Duncan has authored 53 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Medicine, 22 papers in Pharmacology and 21 papers in Infectious Diseases. Recurrent topics in Leonard R Duncan's work include Antibiotic Resistance in Bacteria (36 papers), Antibiotics Pharmacokinetics and Efficacy (21 papers) and Antimicrobial Resistance in Staphylococcus (18 papers). Leonard R Duncan is often cited by papers focused on Antibiotic Resistance in Bacteria (36 papers), Antibiotics Pharmacokinetics and Efficacy (21 papers) and Antimicrobial Resistance in Staphylococcus (18 papers). Leonard R Duncan collaborates with scholars based in United States, Switzerland and Italy. Leonard R Duncan's co-authors include Hélio S. Sader, Robert K. Flamm, Mariana Castanheira, Rodrigo E. Mendes, Michael A. Pfaller, Dee Shortridge, Cecília G Carvalhaes, Timothy B Doyle, Gregory T. Robertson and A. Simon Lynch and has published in prestigious journals such as Journal of Virology, Journal of Bacteriology and Journal of Medicinal Chemistry.

In The Last Decade

Leonard R Duncan

50 papers receiving 985 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leonard R Duncan United States 21 589 428 287 272 251 53 1.0k
Michael Malczynski United States 14 410 0.7× 170 0.4× 208 0.7× 209 0.8× 181 0.7× 40 905
Nenad Maćešić Australia 17 577 1.0× 248 0.6× 275 1.0× 205 0.8× 131 0.5× 41 1.0k
Chris M. Pillar United States 23 573 1.0× 484 1.1× 287 1.0× 623 2.3× 136 0.5× 45 1.4k
Myrto Christofidou Greece 18 411 0.7× 163 0.4× 342 1.2× 221 0.8× 210 0.8× 40 836
Michael Kresken Germany 21 669 1.1× 426 1.0× 474 1.7× 448 1.6× 187 0.7× 73 1.4k
Elisabetta Mantengoli Italy 17 727 1.2× 205 0.5× 230 0.8× 240 0.9× 259 1.0× 27 1.2k
Anne Santerre Henriksen Denmark 16 299 0.5× 237 0.6× 166 0.6× 355 1.3× 123 0.5× 39 793
Lynne Garrity-Ryan United States 15 473 0.8× 244 0.6× 312 1.1× 323 1.2× 153 0.6× 25 1.1k
Ioanna Stefanou Greece 12 663 1.1× 366 0.9× 306 1.1× 141 0.5× 195 0.8× 16 909
Maria M. Traczewski United States 18 487 0.8× 232 0.5× 253 0.9× 312 1.1× 122 0.5× 42 924

Countries citing papers authored by Leonard R Duncan

Since Specialization
Citations

This map shows the geographic impact of Leonard R Duncan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonard R Duncan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonard R Duncan more than expected).

Fields of papers citing papers by Leonard R Duncan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leonard R Duncan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonard R Duncan. The network helps show where Leonard R Duncan may publish in the future.

Co-authorship network of co-authors of Leonard R Duncan

This figure shows the co-authorship network connecting the top 25 collaborators of Leonard R Duncan. A scholar is included among the top collaborators of Leonard R Duncan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leonard R Duncan. Leonard R Duncan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arends, S J Ryan, Jason R. Evans, Brian D. Peyser, et al.. (2023). Screen for New Antimicrobial Natural Products from the NCI Program for Natural Product Discovery Prefractionated Extract Library. ACS Infectious Diseases. 9(6). 1245–1256. 20 indexed citations
2.
Duncan, Leonard R, Mariana Castanheira, Bruce E. Reidenberg, et al.. (2023). 2117. In Vitro Antimicrobial Activity of Taurolidine against Candida auris Bloodstream Isolates from Global Sources. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations
3.
Bhavnani, Sujata M., Jeffrey Hammel, Jennifer I. Smart, et al.. (2023). 2531. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Ceftobiprole Dosing Regimens for Patients with Staphylococcus aureus Bacteremia (SAB). Open Forum Infectious Diseases. 10(Supplement_2).
4.
Ma, Zhenkun, Ying Yuan, Yu Liu, et al.. (2022). Design, Synthesis, and Characterization of TNP-2198, a Dual-Targeted Rifamycin-Nitroimidazole Conjugate with Potent Activity against Microaerophilic and Anaerobic Bacterial Pathogens. Journal of Medicinal Chemistry. 65(6). 4481–4495. 18 indexed citations
5.
Sader, Hélio S., Mariana Castanheira, Leonard R Duncan, & Rodrigo E. Mendes. (2022). Update on the in vitro activity of ceftaroline against Staphylococcus aureus from United States (US) medical centers stratified by infection type (2018−2020). Diagnostic Microbiology and Infectious Disease. 105(1). 115820–115820. 5 indexed citations
6.
Huang, David B., et al.. (2021). In vitro activity of iclaprim and comparator agents against Listeria monocytogenes clinical isolates from 2012 to 2018. Journal of Global Antimicrobial Resistance. 25. 14–17.
7.
Sader, Hélio S., Leonard R Duncan, & Rodrigo E. Mendes. (2021). Antimicrobial activity of dalbavancin and comparators against Staphylococcus aureus causing pneumonia in patients with and without cystic fibrosis. International Journal of Infectious Diseases. 107. 69–71. 2 indexed citations
8.
Duncan, Leonard R, Hélio S. Sader, Michael D. Huband, Robert K. Flamm, & Rodrigo E. Mendes. (2020). Antimicrobial Activity of Telavancin Tested In Vitro Against a Global Collection of Gram-Positive Pathogens, Including Multidrug-Resistant Isolates (2015–2017). Microbial Drug Resistance. 26(8). 934–943. 10 indexed citations
10.
Sader, Hélio S., Paul R. Rhomberg, Leonard R Duncan, et al.. (2020). Antimicrobial activity of POL7306 tested against clinical isolates of Gram-negative bacteria collected worldwide. Journal of Antimicrobial Chemotherapy. 75(6). 1518–1524. 7 indexed citations
11.
Shortridge, Dee, S J Ryan Arends, Leonard R Duncan, Jennifer M Streit, & Robert K. Flamm. (2019). 1589. Ceftolozane–Tazobactam Activity Against Difficult-to-Treat Resistance in Pseudomonas aeruginosa from Bloodstream Infections in US Hospitals. Open Forum Infectious Diseases. 6(Supplement_2). S580–S580. 2 indexed citations
12.
Pfaller, Michael A., Robert K. Flamm, Leonard R Duncan, et al.. (2019). Ceftobiprole activity when tested against contemporary bacteria causing bloodstream infections in the United States (2016–2017). Diagnostic Microbiology and Infectious Disease. 94(3). 304–313. 22 indexed citations
14.
Castanheira, Mariana, Leonard R Duncan, Rodrigo E. Mendes, Hélio S. Sader, & Dee Shortridge. (2017). Activity of Ceftolozane-Tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae Isolates Collected from Respiratory Tract Specimens of Hospitalized Patients in the United States during 2013 to 2015. Antimicrobial Agents and Chemotherapy. 62(3). 50 indexed citations
15.
Flamm, Robert K., Leonard R Duncan, Dee Shortridge, et al.. (2017). Ceftobiprole Activity When Tested Against Contemporary Bacteria Causing Bloodstream Infections in the US (2016). Open Forum Infectious Diseases. 4(suppl_1). S368–S368. 3 indexed citations
16.
Duncan, Leonard R, Hélio S. Sader, Jennifer I. Smart, Robert K. Flamm, & Rodrigo E. Mendes. (2017). Telavancin activity in vitro tested against a worldwide collection of Gram-positive clinical isolates (2014). Journal of Global Antimicrobial Resistance. 10. 271–276. 16 indexed citations
17.
Castanheira, Mariana, Leonard R Duncan, Paul R. Rhomberg, & Hélio S. Sader. (2017). Enhanced activity of cefepime–tazobactam (WCK 4282) against KPC-producing Enterobacteriaceae when tested in media supplemented with human serum or sodium chloride. Diagnostic Microbiology and Infectious Disease. 89(4). 305–309. 13 indexed citations
18.
Pfaller, Michael A., Matteo Bassetti, Leonard R Duncan, & Mariana Castanheira. (2017). Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: report from an antimicrobial surveillance programme (2012–15). Journal of Antimicrobial Chemotherapy. 72(5). 1386–1395. 73 indexed citations
19.
Duncan, Leonard R, Jennifer I. Smart, Robert K. Flamm, et al.. (2016). Telavancin activity tested against a collection of Staphylococcus aureus isolates causing pneumonia in hospitalized patients in the United States (2013–2014). Diagnostic Microbiology and Infectious Disease. 86(3). 300–302. 6 indexed citations
20.
Duncan, Leonard R, Leslie Gay, & John E. Donelson. (1991). African trypanosomes express an immunogenic protein with a repeating epitope of 24 amino acids. Molecular and Biochemical Parasitology. 48(1). 11–16. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026